Publicaciones en colaboración con investigadores/as de Universidad de Navarra (18)

2024

  1. Atención a las personas con dislexia en la formación universitaria: recomendaciones para la gestión institucional y la práctica docente

    Revista de Investigación en Logopedia, Vol. 14, Núm. 2

  2. Evaluation of the psychometric properties of the health care providers’ pain and impairment relationship scale (HC-PAIRS) in health professionals and university students from Chile and Colombia

    Heliyon, Vol. 10, Núm. 14

2020

  1. Psychometric properties of the Weight Locus of Control Scale (MWLCS): study with Spanish individuals of different anthropometric nutritional status

    Eating and Weight Disorders, Vol. 25, Núm. 6, pp. 1533-1542

2016

  1. Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria

    Journal of Hepatology, Vol. 65, Núm. 4, pp. 776-783

2008

  1. IGF-1 gene therapy to protect articular cartilage in a rat model of joint damage

    Archives of Orthopaedic and Trauma Surgery, Vol. 128, Núm. 2, pp. 239-247

2005

  1. Encapsulation of ganciclovir in albumin nanoparticles enhances the thymidine kinase suicide gene therapy

    Journal of Drug Delivery Science and Technology, Vol. 15, Núm. 2, pp. 121-127

  2. Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting

    Journal of Infectious Diseases, Vol. 192, Núm. 5, pp. 920-929

  3. Posibilidades de la terapia génica en el sistema musculoesquelético

    Revista de Ortopedia y Traumatologia, Vol. 49, Núm. 3, pp. 202-213

2004

  1. Evolution of naturally occurring 5′ non-translated region variants of hepatitis C virus genotype 1b in selectable replicons

    Journal of General Virology, Vol. 85, Núm. 7, pp. 1859-1866

2002

  1. The woodchuck interferon-α system: Cloning, family description, and biologic activity

    Journal of Medical Virology, Vol. 68, Núm. 3, pp. 424-432

2001

  1. Gene therapy of hepatocellular carcinoma

    Digestive Diseases, Vol. 19, Núm. 4, pp. 324-332

  2. Gene therapy: its contributions to liver and kidney diseases

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 21 Suppl 1, pp. 17-23

  3. Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12

    Gene Therapy, Vol. 8, Núm. 4, pp. 259-267

  4. Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12

    Journal of Virology, Vol. 75, Núm. 19, pp. 9068-9076

1999

  1. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas

    Gene Therapy, Vol. 6, Núm. 10, pp. 1779-1784

1998

  1. Liver-selective DNA targeting using the asialoglycoprotein receptor

    Biogenic Amines, Vol. 14, Núm. 5, pp. 499-518

1994

  1. Amplification of the c-myc proto-oncogene in soft tissue sarcomas

    Oncology (Switzerland), Vol. 51, Núm. 1, pp. 13-17

  2. Partial splenic embolization for the treatment of hypersplenism in cirrhosis

    Revue Francaise de Gastro-Enterologie